The North America Cardiac Catheters & Guidewires Market would witness market growth of 6.2% CAGR during the forecast period (2022-2028).
A significant element that will drive business expansion in the near future is the increased interest in the development of specialized equipment and treatment methods for problematic PCI patients. The sector is also being propelled by the creation of certain tools and techniques for treating individuals who would otherwise require medical management or undergo Coronary Artery Bypass Graft surgery (CABG).
The major factors that are driving the market for cardiac catheters and guidewires include the growing demand for minimally invasive procedures, the expansion of ambulatory surgical centers and hospitals, the rising incidence of cardiovascular diseases caused by diabetes, the expansion of government programs, the ageing population, etc. The market for cardiac catheters and guidewires has an opportunity for new product development with a focus on patient comfort and the growing elderly population.
In the United States, heart disease is the leading cause of death for both genders and members of the majority of racial and ethnic groups. Cardiovascular disease claims one life in the United States every 34 seconds. In the United States, heart disease claimed the lives of almost 697,000 people in 2020, accounting for 1 in 5 fatalities. This rising prevalence of cardiovascular diseases as well as the better healthcare infrastructure in the region is leading to the large number of cardiac catheterization procedures being conducted in the region. Thus, the market for cardiac catheters & guidewires market would grow in the North America region.
The US market dominated the North America Cardiac Catheters & Guidewires Market by Country in 2021; thereby, achieving a market value of $5,445.2 million by 2028. The Canada market is experiencing a CAGR of 8.7% during (2022 - 2028). Additionally, The Mexico would witness a CAGR of 7.7% during (2022 - 2028).
Based on Product, the market is segmented into Cardiac Catheters and Cardiac Guidewires. Based on Cardiac Catheters Type, the market is segmented into Electrophysiology Catheters, PTCA Balloons Catheters, IVUS Catheters, PTA Balloons Catheters, Guide Extension Catheters and Others. Based on End User, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Cardiac Catheters & Guidewires Market is Predict to reach $19 Billion by 2028, at a CAGR of 7.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Getinge AB, Cardinal Health, Inc., Biotronik SE & Co. KG, Medtronic PLC, Nipro Corporation, Merit Medical Systems, Inc., Teleflex, Inc. and B. Braun Melsungen AG
By Product
By End User
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
